Citations for
1RBM17
Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion.
Al-Ayoubi AM, Zheng H, Liu Y, Bai T, Eblen ST.
Mol Cell Biol 32(14):2880-93. Epub 2012 May 21. 2012
2ATXN1, RBM17, U2AF2
14-3-3 Binding to ataxin-1(ATXN1) regulates its dephosphorylation at Ser-776 and transport to the nucleus.
Lai S, O'Callaghan B, Zoghbi HY, Orr HT.
J Biol Chem 286(40):34606-16. Epub 2011 Aug 11. 2011
3RBM17
U2AF-homology motif interactions are required for alternative splicing regulation by SPF45.
Corsini L, Bonnal S, Basquin J, Hothorn M, Scheffzek K, Valcárcel J, Sattler M.
Nat Struct Mol Biol 14(7):620-9. Epub 2007 Jun 24. Erratum in: Nat Struct Mol Biol. 2007 Aug;14(8):785. Bonna, Sophie [corrected to Bonnal, Sophie]. 2007
4RBM17
Drosophila SPF45: a bifunctional protein with roles in both splicing and DNA repair.
Chaouki AS, Salz HK.
PLoS Genet 2(12):e178. 2006
5RBM17
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators.
Perry WL 3rd, Shepard RL, Sampath J, Yaden B, Chin WW, Iversen PW, Jin S, Lesoon A, O'Brien KA, Peek VL, Rolfe M, Shyjan A, Tighe M, Williamson M, Krishnan V, Moore RE, Dantzig AH.
Cancer Res 65(15):6593-600. 2005
6RBM17
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells.
Sampath J, Long PR, Shepard RL, Xia X, Devanarayan V, Sandusky GE, Perry WL 3rd, Dantzig AH, Williamson M, Rolfe M, Moore RE.
Am J Pathol 163(5):1781-90. 2003
7BCAS2, RBM17, SMNDC1, SNRNP40
Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex.
Neubauer G, King A, Rappsilber J, Calvio C, Watson M, Ajuh P, Sleeman J,Lamond A, Mann M.
Nat Genet 20(1):46-50. 1998